Echinococcus granulosus-specific T-cell lines derived from patients at various clinical stages of cystic echinococcosis
R. Riganò
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Both authors contributed equally to this paper.
Search for more papers by this authorB. Buttari
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Both authors contributed equally to this paper.
Search for more papers by this authorE. De Falco
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorE. Profumo
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorE. Ortona
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorP. Margutti
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorC. Scottà
Department of Cellular and Developmental Biology, University of Rome ‘La Sapienza’, Rome, Italy and
Search for more papers by this authorA. Teggi
Department of Infectious and Tropical Diseases, University of Rome ‘La Sapienza’, Rome, Italy
Search for more papers by this authorCorresponding Author
A. Siracusano
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Dr Alessandra Siracusano, Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy (e-mail: [email protected]).Search for more papers by this authorR. Riganò
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Both authors contributed equally to this paper.
Search for more papers by this authorB. Buttari
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Both authors contributed equally to this paper.
Search for more papers by this authorE. De Falco
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorE. Profumo
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorE. Ortona
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorP. Margutti
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Search for more papers by this authorC. Scottà
Department of Cellular and Developmental Biology, University of Rome ‘La Sapienza’, Rome, Italy and
Search for more papers by this authorA. Teggi
Department of Infectious and Tropical Diseases, University of Rome ‘La Sapienza’, Rome, Italy
Search for more papers by this authorCorresponding Author
A. Siracusano
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Rome,
Dr Alessandra Siracusano, Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161, Rome, Italy (e-mail: [email protected]).Search for more papers by this authorSUMMARY
To investigate the role of T lymphocytes in the immune response to Echinococcus granulosus, using sheep hydatid fluid (SHF) and antigen B (AgB), we generated T-cell lines from patients with active, transitional and inactive hydatid cysts. We established 16 T-cell lines, eight specific to SHF and eight specific to AgB. At surface phenotyping 88–98% of cells displayed the helper/inducer CD4 antigen. In all patients, at all clinical stages of hydatid cyst disease, T-cell stimulation with SHF and AgB invariably amplified a large number of almost identical Vβ subfamily fragments. Irrespective of antigen-specificity, the two cell lines from the patient with an inactive cyst had a Th1 profile, because they exclusively expressed and produced IFN-γ. Conversely, the T-cell lines derived from the seven patients with active and transitional hydatid cysts had mixed Th1/Th2 and Th0 clones. The functional characteristics of the 16 T-cell lines differed markedly in the various clinical stages of cystic echinococcosis, thus providing new in vitro evidence that Th1 lymphocytes contribute decisively to the inactive stage of hydatid disease, Th2 lymphocytes in the active and transitional stages. The parasite-specific T-cell lines, especially the two Th1 lines from the patient with an inactive cyst, may help identify Th1 protective epitopes on SHF and AgB.
REFERENCES
- 1 Siracusano A, Ortona E & Riganò R. Molecular and cellular tools in human cystic echinococcosis. Curr Drug Targets Immune Endocr Metabol Disord 2002; 2: 235–245.
- 2 Zhang W, Li J & McManus DP. Concepts in immunology and diagnosis of hydatid disease. Clin Microb Rev 2003; 16: 18–36.
- 3 Kaufmann SH & Doherty PC. Immunity to infection. Curr Opin Immunol 1997; 9: 453–455.
- 4 Reimann J & Kaufmann SH. Alternative antigen processing pathways in anti-infective immunity. Curr Opin Immunol 1997; 9: 462–469.
- 5 Riganò R, Profumo E, Ioppolo S, et al. Immunological markers indicating the effectiveness of pharmacological treatment in human hydatid disease. Clin Exp Immunol 1995; 102: 281–285.
- 6 Riganò R, Profumo E, Buttari B, Teggi A & Siracusano A. Cytokine gene expression in peripheral blood mononuclear cells from patients with pharmacologically treated cystic echinococcosis. Clin Exp Immunol 1999; 118: 95–101.
- 7 Riganò R, Profumo E, Bruschi F, et al. Modulation of human immune response by Echinococcus granulosus antigen B and its possible role in evading host defences. Infect Immun 2001; 69: 288–296.
- 8 Contigli C, Silva-Teixeira DN, Del Prete G, et al. Phenotype and cytokine profile of Schistosoma mansoni specific T cell lines and clones derived from schistosomiasis patients with distinct clinical forms. Clin Immunol 1999; 91: 338–344.
- 9 Gabaglia CR, Valle MT, Fenoglio D, Barcinski MA & Manca F. CD4 (+) T cell response to Leishmania spp. in non-infected individuals. Hum Immunol 2000; 61: 531–537.
- 10 Pawlowski ZS, Eckert J, Vuitton DA, et al. In WHO/OIE Manual on Echinococcosis in Humans and Animals: A Zoonosis of Global Concern, eds J Eckert, MA Gemmel, FX Meslin, ZS Pawlowski. Paris: World Organisation for Animal Health; 2001: 20–66.
- 11 Rogan MT, Craig PS, Zeyhle E, et al. Evaluation of a rapid dot-ELISA as a field test for the diagnosis of cystic hydatid disease. Trans Royal Soc Trop Med Hyg 1991; 85: 773–777.
- 12 Siracusano A, Teggi A, Quintieri F, et al. Cellular immune responses of hydatid patients to Echinococcus granulosus antigens. Clin Exp Immunol 1988; 72: 400–405.
- 13 Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate–phenol–chloroform extraction. Anal Biochem 1987; 162: 156–159.
- 14 Genevée C, Diu A, Nierat J, et al. An experimentally validated panel of subfamily-specific oligonucleotide primers (V alpha 1-w29/V beta 1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 1992; 22: 1261–1269.
- 15 Riganò R, Profumo E, Ioppolo S, et al. Serum cytokine detection in the clinical follow up of patients with cystic echinococcosis. Clin Exp Immunol 1999; 115: 503–507.
- 16 Hernandez A, O'Connor JE & Mir A. Phenotypic analysis of peripheral lymphocyte subpopulations in hydatid patients. Parasitol Res 1999; 85: 948–950.
- 17 Kilwinski J, Jenne L, Jellen-Ritter A, et al. T lymphocyte cytokine profile at a single cell level in alveolar Echinococcosis. Cytokine 1998; 11: 373–381.
- 18 Manfras BJ, Reuter S, Wendland T & Kern P. Increased activation and oligoclonality of peripheral CD8 (+) T cells in the chronic human helminth infection alveolar echinococcosis. Infect Immun 2002; 70: 1168–1174.
- 19 Rickard MD & Lightowlers MW. In The Biology of Echinococcus and Hydatid Disease, ed. RCA Thompson. London: George Allen & Unwin; 1986: 217–249.
- 20 Li Pira G, Bottone L, Fenoglio D, et al. Analysis of the antigen specific T cell repertoires in HIV infection. Immunol Lett 2001; 79: 85–91.
- 21 Romagnani S. Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease. Int J Clin Laboratory Res 1991; 21: 152–158.
- 22 Moingeon P. Strategies for designing vaccines eliciting Th1 responses in humans. J Biotechnol 2002; 98: 189–198.
- 23 Gonzalez-Sapienza G, Lorenzo C & Nieto A. Improved immunodiagnosis of cystic hydatid disease by using a synthetic peptide with higher diagnostic value than that of its parent protein, Echinococcus granulosus antigen B. J Clin Microbiol 2000; 38: 3979–3983.
- 24 Barbieri M, Fernandez V, Gonzalez G, Luaces VM & Nieto A. Diagnostic evaluation of a synthetic peptide derived from a novel antigen B subunit as related to other available peptides and native antigens used for serology of cystic hydatidosis. Parasite Immunol 1998; 20: 51–61.
- 25 Gonzalez-Sapienza G & Cachau RE. Identification of critical residues of an immunodominant region of Echinococcus granulosus antigen B. J Biol Chem 2003; 278: 20179–20184.
- 26 Probst P, Stromberg E, Ghalib HW, et al. Identification and characterization of T cell-stimulating antigens from Leishmania by CD4 T cell expression cloning. J Immunol 2001; 166: 498–505.